Page last updated: 2024-08-23

paclitaxel and Adnexal Diseases

paclitaxel has been researched along with Adnexal Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daladimos, T; Kalinoglou, N; Karabelis, A; Kosmas, C; Moschovis, D; Mylonakis, N; Panagiotidi, E; Papachrysanthou, T; Politis, P; Tsakonas, G; Tsavaris, N; Vorgias, G	1

Other Studies

1 other study(ies) available for paclitaxel and Adnexal Diseases

Article	Year
Paclitaxel-ifosfamide-carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours. British journal of cancer, 2011, Sep-27, Volume: 105, Issue:7 Topics: Adnexal Diseases; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Mixed Tumor, Malignant; Mixed Tumor, Mullerian; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult	2011

Article

Year

Paclitaxel-ifosfamide-carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours.

British journal of cancer, 2011, Sep-27, Volume: 105, Issue:7

Topics: Adnexal Diseases; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Mixed Tumor, Malignant; Mixed Tumor, Mullerian; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult

2011